Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 5,009 | 3,657 | 5,541 | 1,713 |
| Operating Income | -5,009 | -3,657 | -5,541 | -1,713 |
| Interest Expense | 16 | 3 | 33 | 12 |
| Other Income | -18 | 21 | -2,595 | 78 |
| Pre-tax Income | -5,043 | -3,639 | -8,169 | -1,647 |
| Net Income Continuous | -5,043 | -3,639 | -8,169 | -1,647 |
| Net Income | $-5,043 | $-3,639 | $-8,169 | $-1,647 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.22 | -0.04 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.22 | -0.04 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.22 | N/A |
| EBITDA(a) | $-4,942 | $-3,603 | $-8,122 | $-1,635 |